1. Home
  2. Analysis

Bladder dysfunction and drugs of ingredients of cephalexin (a real world drug study)


Summary:

Bladder dysfunction is found among people who take drugs with ingredients of cephalexin, especially for people who are female, 50-59 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 43,283 people who have side effects when taking drugs with ingredients of cephalexin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Cephalexin, Keflet, Keflex, Panixine disperdose.

On Apr, 03, 2026

43,283 people reported to have side effects when taking drugs with ingredients of cephalexin.
Among them, 12 people (0.03%) have Bladder dysfunction

What is Bladder dysfunction?

Bladder dysfunction is found to be associated with 241 drugs and 274 conditions by eHealthMe. Check the latest studies of Bladder dysfunction.

Number of reports submitted per year:

Could drugs with ingredients of cephalexin cause Bladder dysfunction?

Time on drugs with ingredients of cephalexin when people have Bladder dysfunction *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Bladder dysfunction when taking drugs with ingredients of cephalexin *:

  • female: 91.67 %
  • male: 8.33 %

Age of people who have Bladder dysfunction when taking drugs with ingredients of cephalexin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Breast Cancer: 8 people, 66.67%
  2. Neuropathy Peripheral (surface nerve damage): 7 people, 58.33%
  3. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 58.33%
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 58.33%
  5. Type 1 Diabetes: 1 person, 8.33%
  6. Tumor: 1 person, 8.33%
  7. Postoperative Wound Infection: 1 person, 8.33%
  8. Ovarian Cancer (cancer of ovary): 1 person, 8.33%
  9. Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
  10. Neoplasm Malignant (cancer tumour): 1 person, 8.33%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Zometa: 8 people, 66.67%
  2. Oxycontin: 8 people, 66.67%
  3. Cymbalta: 8 people, 66.67%
  4. Doxycycline: 8 people, 66.67%
  5. Elavil: 8 people, 66.67%
  6. Lasix: 8 people, 66.67%
  7. Neurontin: 8 people, 66.67%
  8. Lidoderm: 8 people, 66.67%
  9. Vicodin: 8 people, 66.67%
  10. Flexeril: 7 people, 58.33%

Other side effects people have besides Bladder dysfunction *:

You may use this to check any potential undetected side effects.

  1. Diarrhea: 11 people, 91.67%
  2. Fatigue (feeling of tiredness): 10 people, 83.33%
  3. Deformity (disfigurement): 9 people, 75.00%
  4. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 9 people, 75.00%
  5. Weakness: 9 people, 75.00%
  6. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 9 people, 75.00%
  7. Nausea And Vomiting: 9 people, 75.00%
  8. Oedema Peripheral (superficial swelling): 9 people, 75.00%
  9. Pain: 9 people, 75.00%
  10. Dizziness: 9 people, 75.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of cephalexin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on cephalexin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.